Casa
carti master plus

Capecitabine, DNA/RNA Synthesis Inhibitor

Por um escritor misterioso

Descrição
Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.
Capecitabine, DNA/RNA Synthesis Inhibitor
Full article: DNA synthesis inhibitors for the treatment of gastrointestinal cancer
Capecitabine, DNA/RNA Synthesis Inhibitor
Capecitabine API Manufacturer and Supplier
Capecitabine, DNA/RNA Synthesis Inhibitor
Chemotherapy
Capecitabine, DNA/RNA Synthesis Inhibitor
Capecitabine, DNA, RNA and Protein Synthesis Inhibitors
Capecitabine, DNA/RNA Synthesis Inhibitor
DNA and RNA Synthesis: Antifolates
Capecitabine, DNA/RNA Synthesis Inhibitor
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients
Capecitabine, DNA/RNA Synthesis Inhibitor
Anti-Cancer Drugs-Medicinal Chemistry
Capecitabine, DNA/RNA Synthesis Inhibitor
Capecitabine-d11 (CAS Number: 1132662-08-8)
Capecitabine, DNA/RNA Synthesis Inhibitor
APExBIO - Capecitabine
Capecitabine, DNA/RNA Synthesis Inhibitor
Mapping combinatorial drug effects to DNA damage response kinase inhibitors
Capecitabine, DNA/RNA Synthesis Inhibitor
Frontiers Co-delivery of Cisplatin(IV) and Capecitabine as an Effective and Non-toxic Cancer Treatment
Capecitabine, DNA/RNA Synthesis Inhibitor
Capecitabine, C15H22FN3O6
de por adulto (o preço varia de acordo com o tamanho do grupo)